GENERIC CLASSIFICATION MODE OF INDICATION ADVERSE ROUTE NURSING RESPONSIBILITIES

NAME/BRAND ACTION EFFECT

NAME

CETRIZINE Therapeutic: Antagonize Relief of ORAL • Assess allergy

AllerTec allergy, cold, andthe effects of allergic CNS: symptoms (rhinitis,
cough remedies, histamine at symptoms dizziness, conjunctivitis, hives)
antihistamines H1-receptor caused by before and periodically
drowsiness,
sites, histamine during therapy.
Pharmacologic: preventing release fatigue
Histamine Receptor allergic including: • Assess lung sounds and
antagonist response. Also seasonal and CV:
character of bronchial
has mild perennial palpitations, secretions. Maintain fluid
bronchodilator allergic rhinitis, edema intake of 15000-
y effects and Chronic 2000ml/day to decrease
blocks urticaria. EENT: viscosity of secretions.
histamine- pharyngitis
induced • Lab Test
broncho- GI: dry mouth, Considerations: may
constriction nausea, cause false-negative
vomiting, result in allergy skin
testing.
abdominal
distress

Respiratory:
bronchospasm
 GENERIC CLASSIFICATION MODE OF INDICATION ADVERSE ROUTE NURSING RESPONSIBILITIES
NAME/ ACTION EFFECT
BRAND
NAME

ALBUTEROL Bronchodilators : Increase in Use as Inhalation • Assess lung sounds,

cyclic-3, 5- bronchodilator to CNS: pulse, blood pressure
Salbutamol nervousness,
adenosine control and before administration and
space prevent restlessness, during peak of
monophosphat reversible airway tremors, medication. Note
e (CAMP), obstruction headache, amount, color, and
activate cause by asthma insomnia, character of sputum
kinases, which or COPD. hyperactivism produced.
inhibit the Inhalation: use in children.
phosphorylatio as quick -relief • Monitor pulmonary
n of myosin agent for acute CV: chest pain, function test before
and decrease bronchospasm hypertension. initiating therapy and
intracellular and prevention periodically during
GI: nausea,
calcium. of exercise- therapy to determine
vomiting.
Decrease induced effectiveness on
intracellular bronchospasm. Endo: medication.
calcium PO: use as a hyperglycemia
relaxes smooth long term control • Observe for paradoxical
muscle agent in patients F&E: bronchospasm. If
airways. with hypokalemia condition occurs, with
Relaxation of chronic/persisten hold medication and
airway smooth t bronchospasm. notify physician and other
muscle with health care professional
subsequent immediately.
bronchodilation
GENERIC CLASSIFICATION MODE OF INDICATION ADVERSE ROUTE NURSING RESPONSIBILITIES
NAME/ ACTION EFFECT
BRAND
NAME
 GI: lhepatic
PARACET Antipyretics Inhibits the M failure, ORAL • Monitor VS esp. temp.
Analgesics synthesis of I hepatotoxicity
AMOL • Assess malnutrition or
prostaglandin L
Calpol that acts as the D GU: renal increase risk for
mediators of failure developing hepatotoxicity
pain and fever. P with chronic use of usual
A Derm: rashes, dose of this drug.
I irticaira
N • Assess overall health
Hemat: status and alcohol usage
neutropenia before administering
&
paracetamol.
F
• Assess malnutrition or
E
alcohol abuse, increase
V
risk for developing
E
hepotoxicity with chronic
R
use of usual dose of this
drug.
 GENERIC CLASSIFICATION MODE OF INDICATION ADVERSE ROUTE NURSING RESPONSIBILITIES
NAME/ ACTION EFFECT
BRAND
NAME

CEFUROXIME Therapeutic: anti-Interferes with Moderate to CNS: ORAL • Assess for infection (vital signs;
Zinnat infective bacterial cell- severe infections, headache, appearance of wound, sputum,
urine, and stool; WBC) at
wall synthesis including those of hyper activity, beginning and during therapy.
Pharmacologic: and division by skin, bone, joints, hypertonia
second-generation binding to cell urinary or GI: • Before initiating therapy, obtain
cephalosporin wall, causing respiratory tract, pseudomembr a history to determine previous
cell to die. gynecologic anous colitis, use of and reactions to
penicillines or cephalosporins.
Active against infections, and diarrhea, Person with a negative history of
gram-negative septicemia. abdominal penicillin sensitivity may still
and gram- pain, nausea, have an allergic response.
positive vomiting
bacteria, with GU: • Obtain specimens for culture
and sensitivity before initiating
expanded hematuria, therapy. First dose may be given
activity against renal before receiving results.
gram-negative dysfunction
bacteria. Hemat: • Observe patients for s/s of
anaphylaxis (rash, pruritus,
Exhibits hemorrhage,
laryngeal edema, wheezing).
minimal hemolytic Discontinue the drug and notify
immunosuppre anemia physician or other heath care
ssant activity. Metabolic: professional immediately if these
hyperglycemia symptoms occur. Keep
epinephrine, an antihistamine,
Misc:
and resuscitation equipment
anaphylaxis, close by in the event of an
allergic anaphylactic reaction.
reaction
GENERIC CLASSIFICATION MODE OF INDICATION ADVERSE ROUTE NURSING RESPONSIBILITIES
NAME/ ACTION EFFECT
BRAND
NAME

Procaterol adrenergics Inhibit the oral 1. Careful Administration (Meptin®

HCl phosphorylatio Relief of dyspnea Palpitation, should be administered with care in
beta-2- n of myosin and other tachycardia. the following patients.)
Meptin Tremor, a. Patients with hyperthyroidism (the
adrenoreceptor and decrease symptoms
headache & disease may be exacerbated.)
agonists intracellular caused by b. Patients with hypertension (Blood
calcium. respiratory dull headache.
Nausea, pressure may further increase.)
Decrease obstructive c. Patients with heart disease
intracellular disturbance in the vomiting. (Palpitation, arrhythmias,
calcium relaxes following exacerbation of heart disease, and
smooth muscle diseases: other symptoms may occur.)
airways. bronchial asthma, d. Patients with diabetes mellitus
Relaxation of chronic (The disease may be exacerbated.)
airway smooth bronchitis, and e. Patients during pregnancy or
muscle with pulmonary suspected pregnancy (See Use
during Pregnancy or Lactation
subsequent emphysema.
section.)
bronchodilation
a. If the desired therapeutic effect of
Meptin® syrup has not been
achieved at the recommended dose,
the drug should be discontinued
b. Continuous administration of
excessive amounts of this drug may
cause cardiac arrhythmia and
cardiac arrest. Special care should
therefore be taken not to exceed the
recommended dose of this drug.